Annual D&A
$16.43 M
+$2.77 M+20.32%
November 30, 2024
Summary
- As of February 8, 2025, NRIX annual depreciation & amortization is $16.43 million, with the most recent change of +$2.77 million (+20.32%) on November 30, 2024.
- During the last 3 years, NRIX annual D&A has risen by +$10.35 million (+170.11%).
- NRIX annual D&A is now at all-time high.
Performance
NRIX Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$4.30 M
+$157.00 K+3.79%
November 30, 2024
Summary
- As of February 8, 2025, NRIX quarterly depreciation & amortization is $4.30 million, with the most recent change of +$157.00 thousand (+3.79%) on November 30, 2024.
- Over the past year, NRIX quarterly D&A has increased by +$415.00 thousand (+10.67%).
- NRIX quarterly D&A is now at all-time high.
Performance
NRIX Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$16.43 M
+$546.00 K+3.44%
November 30, 2024
Summary
- As of February 8, 2025, NRIX TTM depreciation & amortization is $16.43 million, with the most recent change of +$546.00 thousand (+3.44%) on November 30, 2024.
- Over the past year, NRIX TTM D&A has increased by +$2.07 million (+14.39%).
- NRIX TTM D&A is now at all-time high.
Performance
NRIX TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
NRIX Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +20.3% | +10.7% | +14.4% |
| 3 y3 years | +170.1% | +35.3% | +40.0% |
| 5 y5 years | +597.9% | +35.3% | +40.0% |
NRIX Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +170.1% | at high | +167.3% | at high | +170.1% |
| 5 y | 5-year | at high | +653.6% | at high | +776.4% | at high | +3245.8% |
| alltime | all time | at high | +653.6% | at high | +776.4% | at high | +3245.8% |
Nurix Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Nov 2024 | $16.43 M(+20.3%) | $4.30 M(+3.8%) | $16.43 M(+3.4%) |
| Aug 2024 | - | $4.15 M(+1.3%) | $15.88 M(+5.0%) |
| May 2024 | - | $4.09 M(+5.2%) | $15.12 M(+5.3%) |
| Feb 2024 | - | $3.89 M(+3.5%) | $14.36 M(+5.2%) |
| Nov 2023 | $13.65 M(+26.3%) | $3.76 M(+11.0%) | $13.65 M(+5.6%) |
| Aug 2023 | - | $3.38 M(+1.5%) | $12.93 M(+4.0%) |
| May 2023 | - | $3.33 M(+4.8%) | $12.44 M(+6.0%) |
| Feb 2023 | - | $3.18 M(+4.7%) | $11.73 M(+8.6%) |
| Nov 2022 | $10.81 M | $3.04 M(+5.2%) | $10.81 M(+15.2%) |
| Aug 2022 | - | $2.89 M(+9.7%) | $9.38 M(+15.8%) |
| May 2022 | - | $2.63 M(+16.8%) | $8.10 M(+16.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Feb 2022 | - | $2.25 M(+39.9%) | $6.95 M(+14.3%) |
| Nov 2021 | $6.08 M(+179.0%) | $1.61 M(+0.1%) | $6.08 M(+18.9%) |
| Aug 2021 | - | $1.61 M(+8.7%) | $5.12 M(+26.1%) |
| May 2021 | - | $1.48 M(+6.8%) | $4.06 M(+32.0%) |
| Feb 2021 | - | $1.39 M(+115.1%) | $3.07 M(+41.0%) |
| Nov 2020 | $2.18 M(-7.4%) | $644.00 K(+17.1%) | $2.18 M(+41.9%) |
| Aug 2020 | - | $550.00 K(+11.1%) | $1.54 M(+55.8%) |
| May 2020 | - | $495.00 K(+0.8%) | $986.00 K(+100.8%) |
| Feb 2020 | - | $491.00 K | $491.00 K |
| Nov 2019 | $2.35 M(-21.2%) | - | - |
| Nov 2018 | $2.99 M | - | - |
FAQ
- What is Nurix Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Nurix Therapeutics?
- What is Nurix Therapeutics annual D&A year-on-year change?
- What is Nurix Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Nurix Therapeutics?
- What is Nurix Therapeutics quarterly D&A year-on-year change?
- What is Nurix Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Nurix Therapeutics?
- What is Nurix Therapeutics TTM D&A year-on-year change?
What is Nurix Therapeutics annual depreciation & amortization?
The current annual D&A of NRIX is $16.43 M
What is the all time high annual D&A for Nurix Therapeutics?
Nurix Therapeutics all-time high annual depreciation & amortization is $16.43 M
What is Nurix Therapeutics annual D&A year-on-year change?
Over the past year, NRIX annual depreciation & amortization has changed by +$2.77 M (+20.32%)
What is Nurix Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of NRIX is $4.30 M
What is the all time high quarterly D&A for Nurix Therapeutics?
Nurix Therapeutics all-time high quarterly depreciation & amortization is $4.30 M
What is Nurix Therapeutics quarterly D&A year-on-year change?
Over the past year, NRIX quarterly depreciation & amortization has changed by +$415.00 K (+10.67%)
What is Nurix Therapeutics TTM depreciation & amortization?
The current TTM D&A of NRIX is $16.43 M
What is the all time high TTM D&A for Nurix Therapeutics?
Nurix Therapeutics all-time high TTM depreciation & amortization is $16.43 M
What is Nurix Therapeutics TTM D&A year-on-year change?
Over the past year, NRIX TTM depreciation & amortization has changed by +$2.07 M (+14.39%)